13F reference period
Q3 2026
CUSIP: 68062P106
13F reference period
Q3 2026
Institutions Reporting
127
Shares (Excl. Options)
Price
$8.64
The headline uses the Q3 2026 reference period after its reporting deadline. Available reports may still be incomplete or amended.
Watchlists follow companies and investors, across their share classes. Bookmark this page to revisit this specific CUSIP and its quarterly holders. If you create an account from here, we will bring you back after verification.
Latest holder context comes from 127 institutions filings for Q3 2026.
Security key
68062P106
13F reference period
Q3 2026
13F holders
127
13D/G owners
9
CIK / CUSIP context first
Broader feeds
Open recent reporting periods for CUSIP 68062P106:
13D/G owners
Large-stake holder rows connected to Schedule 13D/G evidence.
| Filer | Ownership | Change % | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|
| FMR LLC | 14% | +10% | $143,813,985 | +$24,737,094 | 12,075,062 | +21% | FMR LLC | 30 Jun 2026 |
| BIOTECHNOLOGY VALUE FUND L P | 9.8% | $77,238,382 | 8,939,731 | BVF PARTNERS L P/IL | 14 Oct 2026 | |||
| Bain Capital Life Sciences Opportunities IV, L.P. | 8.2% | -18% | $111,425,979 | -$15,437,859 | 7,473,238 | -12% | Bain Capital Life Sciences Opportunities IV, L.P. | 31 Mar 2026 |
| Paradigm Biocapital Advisors LP | 10% | $37,443,949 | 7,429,355 | Paradigm BioCapital Advisors LP | 31 Dec 2024 | |||
| Janus Henderson Group Ltd. | 7.2% | -12% | $50,038,956 | -$6,260,269 | 6,318,050 | -11% | JANUS HENDERSON GROUP Ltd. | 30 Sep 2026 |
| BlackRock, Inc. | 7.1% | $78,115,092 | 6,244,212 | BlackRock, Inc. | 30 Jun 2026 | |||
| Invus Global Management, LLC | 5.1% | $108,693,078 | 4,461,949 | Raymond Debbane | 16 Mar 2026 | |||
| Logos Global Management LP | 4.7% | $16,172,730 | 3,208,875 | Logos Global Management LP | 18 Mar 2025 | |||
| Point72 Asset Management, L.P. | 2.3% | $7,781,412 | 1,543,931 | Point72 Asset Management, L.P. | 31 Mar 2025 |
13F concentration
Largest 13F positions for this security by reported shares and value.
| Institution | Ownership % | Shares Held | Share Change % | Portfolio % | Holdings Value |
|---|---|---|---|---|---|
| Paradigm Biocapital Advisors LP | 9.9% | 8,720,576 | 1.5% | $75,345,777 | |
| Bain Capital Life Sciences Investors, LLC | 8.1% | 7,085,249 | 4.1% | $61,216,551 | |
| Janus Henderson Group Ltd. | 7.2% | 6,318,050 | 0.02% | $54,562,060 | |
| BVF INC/IL | 6% | 5,295,893 | 1.5% | $45,756,516 | |
| Siren, L.L.C. | 5.5% | 4,856,949 | 0.99% | $41,964,039 | |
| STATE STREET CORP | 4.4% | 3,847,478 | 0% | $33,242,210 | |
| VANGUARD CAPITAL MANAGEMENT LLC | 4% | 3,513,193 | 0% | $30,353,988 | |
| Logos Global Management LP | 3.7% | 3,208,875 | 1.6% | $27,724,680 | |
| Deep Track Capital, LP | 2.4% | 2,109,951 | 0.31% | $18,229,977 | |
| GEODE CAPITAL MANAGEMENT, LLC | 2.2% | 1,969,909 | 0% | $17,023,358 | |
| Cormorant Asset Management, LP | 2% | 1,750,000 | 1% | $15,120,000 | |
| DIMENSIONAL FUND ADVISORS LP | 1.8% | 1,552,837 | 0% | $13,415,730 | |
| GOLDMAN SACHS GROUP INC | 1.7% | 1,485,119 | 0% | $12,831,429 | |
| Defilade Capital Management, L.P. | 1.6% | 1,440,157 | 2.1% | $12,442,956 | |
| LIGHTSPEED MANAGEMENT COMPANY, L.L.C. | 1.5% | 1,355,299 | 0.58% | $11,709,783 | |
| VANGUARD PORTFOLIO MANAGEMENT LLC | 1.5% | 1,327,446 | 0% | $11,469,133 | |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 1.4% | 1,200,000 | 1.5% | $10,368,000 | |
| Duquesne Family Office LLC | 1.1% | 986,827 | 0.21% | $8,526,000 | |
| Point72 Asset Management, L.P. | 1% | 910,579 | 0.01% | $7,867,403 | |
| Qube Research & Technologies Ltd | 0.93% | 819,155 | 0.01% | $7,077,499 | |
| Hudson Bay Capital Management LP | 0.8% | 700,060 | 0.03% | $6,048,518 | |
| Vivo Capital, LLC | 0.77% | 671,843 | 0.64% | $5,804,724 | |
| TWO SIGMA INVESTMENTS, LP | 0.75% | 660,806 | 0% | $5,709,364 | |
| ALGERT GLOBAL LLC | 0.72% | 631,151 | 0.07% | $5,453,145 | |
| Woodline Partners LP | 0.67% | 588,030 | 0.02% | $5,080,579 |
Quarter history
Holder count, reported shares/value, and median price by quarter.
| Period | 13F Shares, Excl. Options | Value, Excl. Options | Value Change | Price (Median) | Investors |
|---|---|---|---|---|---|
| 2026 Q3 | 77,562,324 | $667,645,721 | -$2,849,019 | $8.64 | 127 |
| 2026 Q2 | 101,921,779 | $1,275,247,437 | -$15,317,512 | $12.51 | 183 |
| 2026 Q1 | 101,411,965 | $1,511,791,691 | +$99,305,974 | $14.91 | 193 |
| 2025 Q4 | 90,695,275 | $2,267,572,776 | +$591,383,435 | $25.00 | 198 |
| 2025 Q3 | 68,238,531 | $668,036,044 | -$3,229,086 | $9.79 | 124 |
| 2025 Q2 | 70,511,948 | $300,429,144 | +$22,565,282 | $4.26 | 120 |
| 2025 Q1 | 65,888,228 | $247,927,417 | -$30,654,965 | $3.76 | 131 |
| 2024 Q4 | 71,278,859 | $415,382,388 | +$48,509,843 | $5.83 | 154 |
| 2024 Q3 | 58,658,581 | $700,332,942 | +$12,555,131 | $11.94 | 129 |
| 2024 Q2 | 57,896,539 | $626,445,097 | +$18,080,243 | $10.82 | 127 |
| 2024 Q1 | 56,110,675 | $635,162,151 | +$37,635,929 | $11.32 | 125 |
| 2023 Q4 | 51,618,204 | $717,066,039 | +$56,526,765 | $14.03 | 113 |
| 2023 Q3 | 47,322,813 | $584,436,985 | +$135,063,720 | $12.35 | 97 |
| 2023 Q2 | 36,408,086 | $328,764,561 | +$43,216,272 | $9.03 | 86 |
| 2023 Q1 | 33,447,196 | $116,103,891 | +$1,469,913 | $3.47 | 65 |
| 2022 Q4 | 33,334,567 | $81,640,055 | -$481,138 | $2.45 | 66 |
| 2022 Q3 | 33,359,693 | $92,063,140 | -$4,143,577 | $2.76 | 67 |
| 2022 Q2 | 34,202,982 | $139,234,855 | -$8,391,103 | $4.07 | 70 |
| 2022 Q1 | 36,374,849 | $155,206,361 | -$17,958,891 | $4.26 | 86 |
| 2021 Q4 | 38,428,075 | $359,510,482 | -$41,441,250 | $9.36 | 94 |
| 2021 Q3 | 36,741,334 | $1,012,524,920 | -$19,680,898 | $27.56 | 75 |
| 2021 Q2 | 37,428,321 | $1,047,268,923 | +$59,576,299 | $27.98 | 68 |
| 2021 Q1 | 35,240,926 | $1,158,274,244 | -$1,710,105 | $33.18 | 73 |
| 2020 Q4 | 35,073,865 | $1,657,230,008 | +$1,657,206,010 | $48.08 | 56 |